Valeo Financial Advisors LLC Purchases 109 Shares of HCA Healthcare, Inc. (NYSE:HCA)

Valeo Financial Advisors LLC grew its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 11.5% during the 3rd quarter, HoldingsChannel reports. The institutional investor owned 1,060 shares of the company’s stock after purchasing an additional 109 shares during the quarter. Valeo Financial Advisors LLC’s holdings in HCA Healthcare were worth $431,000 at the end of the most recent reporting period.

Several other institutional investors also recently bought and sold shares of HCA. Capital World Investors grew its holdings in HCA Healthcare by 57.5% during the 1st quarter. Capital World Investors now owns 2,792,377 shares of the company’s stock valued at $931,342,000 after buying an additional 1,019,750 shares in the last quarter. Lee Danner & Bass Inc. bought a new position in HCA Healthcare during the second quarter valued at $131,527,000. Darsana Capital Partners LP raised its position in shares of HCA Healthcare by 53.3% during the 2nd quarter. Darsana Capital Partners LP now owns 1,150,000 shares of the company’s stock valued at $369,472,000 after buying an additional 400,000 shares in the last quarter. Swedbank AB purchased a new stake in HCA Healthcare during the first quarter valued at approximately $95,882,000. Finally, TD Asset Management Inc lifted its position in HCA Healthcare by 30.4% in the first quarter. TD Asset Management Inc now owns 721,318 shares of the company’s stock worth $240,581,000 after buying an additional 168,093 shares during the last quarter. 62.73% of the stock is owned by hedge funds and other institutional investors.

HCA Healthcare Stock Performance

Shares of HCA Healthcare stock opened at $396.09 on Tuesday. The firm has a market capitalization of $103.74 billion, a P/E ratio of 19.75, a PEG ratio of 1.44 and a beta of 1.67. The company has a quick ratio of 0.94, a current ratio of 1.06 and a debt-to-equity ratio of 27.11. HCA Healthcare, Inc. has a 52 week low of $215.96 and a 52 week high of $409.42. The company has a 50 day moving average price of $388.06 and a 200 day moving average price of $347.97.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings data on Tuesday, July 23rd. The company reported $5.50 EPS for the quarter, beating the consensus estimate of $4.97 by $0.53. The business had revenue of $17.49 billion for the quarter, compared to the consensus estimate of $17.05 billion. HCA Healthcare had a net margin of 8.40% and a return on equity of 553.13%. The business’s revenue for the quarter was up 10.3% on a year-over-year basis. During the same period in the prior year, the firm earned $4.29 EPS. Sell-side analysts expect that HCA Healthcare, Inc. will post 22.51 EPS for the current year.

HCA Healthcare Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Monday, September 30th. Shareholders of record on Monday, September 16th were issued a dividend of $0.66 per share. This represents a $2.64 annualized dividend and a yield of 0.67%. The ex-dividend date of this dividend was Monday, September 16th. HCA Healthcare’s payout ratio is 13.16%.

Analyst Upgrades and Downgrades

Several equities research analysts have recently issued reports on HCA shares. Royal Bank of Canada raised their target price on shares of HCA Healthcare from $378.00 to $405.00 and gave the stock an “outperform” rating in a report on Friday, August 23rd. Cantor Fitzgerald reiterated an “overweight” rating and issued a $392.00 price target on shares of HCA Healthcare in a report on Tuesday, October 1st. Oppenheimer increased their target price on HCA Healthcare from $345.00 to $390.00 and gave the stock an “outperform” rating in a research note on Wednesday, July 24th. Truist Financial raised their price target on shares of HCA Healthcare from $390.00 to $430.00 and gave the stock a “buy” rating in a research note on Monday, August 19th. Finally, Leerink Partners raised their target price on shares of HCA Healthcare from $367.00 to $396.00 and gave the stock an “outperform” rating in a research report on Wednesday, July 24th. Five research analysts have rated the stock with a hold rating, fourteen have issued a buy rating and four have issued a strong buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $365.65.

Insider Buying and Selling

In related news, SVP Christopher F. Wyatt sold 4,000 shares of HCA Healthcare stock in a transaction that occurred on Monday, July 29th. The stock was sold at an average price of $360.20, for a total transaction of $1,440,800.00. Following the transaction, the senior vice president now owns 40,449 shares in the company, valued at approximately $14,569,729.80. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. In related news, SVP Kathryn A. Torres sold 1,857 shares of the business’s stock in a transaction dated Thursday, July 25th. The shares were sold at an average price of $355.05, for a total value of $659,327.85. Following the sale, the senior vice president now directly owns 17,755 shares in the company, valued at approximately $6,303,912.75. The trade was a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, SVP Christopher F. Wyatt sold 4,000 shares of HCA Healthcare stock in a transaction dated Monday, July 29th. The shares were sold at an average price of $360.20, for a total transaction of $1,440,800.00. Following the sale, the senior vice president now owns 40,449 shares of the company’s stock, valued at approximately $14,569,729.80. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 17,202 shares of company stock worth $6,407,273. 1.60% of the stock is owned by corporate insiders.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.